Showing results (561-570 of 607) with videos related to
Sort By:
Pageof 61
Cancer Science|April 7, 2023
Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinomaOrasa Panawan, Atit Silsirivanit, Chih-Hsiang Chang, et al.Human Cell|October 9, 2025
Establishment of human histiocytic sarcoma organoids dependent on the SHH/YAP pathwayYusuke Yoshimura, Keiichi Yoshida, Yukiko Matsuoka, et al.Skeletal Radiology|September 27, 2023
Coefficient of variation of T2-weighted MRI may predict the prognosis of malignant peripheral nerve sheath tumorMakoto Emori, Hiroyuki Tsuchie, Hiroyuki Takashima, et al.Joint Bone Spine|May 27, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2023
Bone marrow-derived fibroblast migration via periostin causes irreversible arthrogenic contracture after joint immobilizationHirotaka Iura, Kazu Kobayakawa, Hirokazu Saiwai, et al.Frontiers in Immunology|November 29, 2023
Zinc deficiency impairs axonal regeneration and functional recovery after spinal cord injury by modulating macrophage polarization via NF-κB pathwayKen Kijima, Gentaro Ono, Kazu Kobayakawa, et al.International Journal of Hematology|September 9, 2016
Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 casesYusuke Koizumi, Tomoko Uehira, Yasunori Ota, et al.RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.Modern Rheumatology|March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.Cancer Research|February 21, 2012
Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasisMotoyoshi Endo, Masahiro Nakano, Tsuyoshi Kadomatsu, et al.Pageof 61